AXDX实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (2 May 2024 @ 04:00):

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East...

Stats
今日成交量	15 127.00
平均成交量	69 337.00
市值	20.26M
EPS	$0 ( 2024-03-28 )
下一个收益日期	( $-0.720 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.190
ATR14	$0.0110 (1.18%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-17	Phillips Jack	Buy	59 928	Common Stock
2024-04-17	Phillips Jack	Sell	26 735	Common Stock
2024-04-17	Phillips Jack	Sell	59 928	Employee Restricted Stock Units
2024-04-12	Phillips Jack	Buy	59 928	Common Stock
2024-04-12	Phillips Jack	Sell	26 545	Common Stock

INSIDER POWER
96.80
Last 100 transactions
Buy: 51 589 751 \| Sell: 625 027

Accelerate Diagnostics 相关性

10 最正相关
APOP	0.891
SONM	0.887
EA	0.881
MRACW	0.861
RBNC	0.857
ALIM	0.856
SVOK	0.849
EQRX	0.848
GHVI	0.847
PAIC	0.843

10 最负相关
MMAC	-0.943
PKW	-0.908
PID	-0.902
VONV	-0.9
IUSV	-0.896
PVAL	-0.896
LOPE	-0.895
IOSP	-0.894
TCFC	-0.892
RNDV	-0.89

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Accelerate Diagnostics 财务报表

Annual	2023
营收:	$12.06M
毛利润:	$2.55M (21.15 %)
EPS:	$-4.94

FY	2023
营收:	$12.06M
毛利润:	$2.55M (21.15 %)
EPS:	$-4.94

FY	2022
营收:	$12.75M
毛利润:	$3.30M (25.90 %)
EPS:	$-7.61

FY	2021
营收:	$11.78M
毛利润:	$-381 000 (-3.23 %)
EPS:	$-1.260

Financial Reports:

No articles found.

Accelerate Diagnostics

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.